Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Using finasteride with TIP extends time off period for prostate cancer patients.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Tamoxifen effectively treats gynecomastia without causing impotence.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Inactive hair follicle stem cells help prevent skin cancer.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.